|
METTL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63850052917292E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.81360000140307E-08 |
| Normal-vs-Stage2 |
1.245030E-04 |
| Normal-vs-Stage3 |
1.35609999996067E-06 |
| Normal-vs-Stage4 |
1.34699999998489E-06 |
| Stage1-vs-Stage2 |
1.229590E-01 |
| Stage1-vs-Stage3 |
2.297800E-01 |
| Stage1-vs-Stage4 |
6.459600E-02 |
| Stage2-vs-Stage3 |
4.836600E-01 |
| Stage2-vs-Stage4 |
9.475000E-01 |
| Stage3-vs-Stage4 |
4.684200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.15839560166364E-11 |
| Normal-vs-AfricanAmerican |
9.718400E-03 |
| Normal-vs-Asian |
5.409000E-01 |
| Caucasian-vs-AfricanAmerican |
1.540380E-01 |
| Caucasian-vs-Asian |
2.203400E-01 |
| AfricanAmerican-vs-Asian |
4.719000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10270048437178E-10 |
| Normal-vs-Female |
3.79630005209464E-09 |
| Male-vs-Female |
8.210600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.818580E-01 |
| Normal-vs-Age(41-60Yrs) |
9.66109999778197E-08 |
| Normal-vs-Age(61-80Yrs) |
3.23580051642125E-11 |
| Normal-vs-Age(81-100Yrs) |
8.195000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.650500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.223700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.988500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.770000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.564200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.670800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.991600E-02 |
| Normal-vs-Grade 2 |
5.19840004375993E-09 |
| Normal-vs-Grade 3 |
7.81010034422991E-10 |
| Normal-vs-Grade 4 |
3.952500E-04 |
| Grade 1-vs-Grade 2 |
1.020190E-01 |
| Grade 1-vs-Grade 3 |
7.567700E-02 |
| Grade 1-vs-Grade 4 |
1.344820E-01 |
| Grade 2-vs-Grade 3 |
8.094400E-01 |
| Grade 2-vs-Grade 4 |
7.807200E-01 |
| Grade 3-vs-Grade 4 |
8.873400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62558855265615E-12 |
| Normal-vs-ccB subtype |
1.025980E-02 |
| ccA subtype-vs-ccB subtype |
1.08529999998108E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6216999965124E-08 |
| Normal-vs-N1 |
4.888000E-02 |
| N0-vs-N1 |
4.158200E-01 |
|
|
